These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5657038)

  • 1. Immunization of mice to Sarcoma 180 and Ehrlich carcinoma with ultraviolet-killed tumor vaccine.
    Littman ML; Kim YC; Suk D
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):7-17. PubMed ID: 5657038
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of resistance against Ehrlich carcinoma by tumor cells sensitized with immunized rabbit serum.
    Kato N; Ito S; Mizuno D
    Gan; 1972 Apr; 63(2):173-9. PubMed ID: 5070236
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor.
    Nakashima Y
    Acta Med Okayama (1952); 1969 Aug; 23(4):283-90. PubMed ID: 4243561
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I; Halonen P
    J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunostimulating effect of Listeria monocytogenes, BCG and their biologically active extracts on the model of mouse ascites tumors.
    Mára M; Nedvĕdová V; Miková Z; Hyncica V
    Neoplasma; 1979; 26(6):703-10. PubMed ID: 120515
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance to Ehrlich's ascites carcinoma in mice immunized with killed tumor cells].
    D'Alessandro G; Giammanco G; Barncato P
    Riv Ist Sieroter Ital; 1967; 42(6):332-49. PubMed ID: 5601777
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between subcutaneous and intraperitoneal transplants of the Ehrlich carcinoma; the possible role of anti-tumour antibody.
    Hallerbaker B; Hartveit F
    J Pathol; 1971 Oct; 105(2):95-103. PubMed ID: 5135342
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on immune response of experimental tumors--observations on the immune response of lymph nodes of mice bearing implanted Ehrlich ascitic tumor or sarcoma 180 (author's transl)].
    Chen QF; Zhou SL; Liu QR
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):193-6. PubMed ID: 7227183
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F; Halleraker B
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
    Hager EB; Bailey GL; Hampers CL; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):124-5. PubMed ID: 4944208
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological studies of the influence of isologous lymphocytes on the growth of the Ehrlich-ascites-tumor.
    Warnatz H; Scheiffarth F; Schmidt G
    Int Arch Allergy Appl Immunol; 1966; 30(3):238-47. PubMed ID: 5929010
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of action and cytotoxic, biochemical and histochemical effects of antibodies and complement on neoplastic cells and experimental malignant neoplasms].
    Valguarnera G
    Ann Sclavo; 1974; 16(4):367-85. PubMed ID: 4441141
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection of mice from malignant tumor implants by enucleated tumor cells.
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1974 Oct; 53(4):1175-6. PubMed ID: 4372368
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune response in tumor-bearing mice.
    Kamo I; Ishida N
    Gan; 1971 Dec; 62(6):453-8. PubMed ID: 4946503
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between tumor incompatibility and therapeutic response.
    Ferrer JF; Mihich E
    Proc Soc Exp Biol Med; 1967 Nov; 126(2):402-5. PubMed ID: 6079912
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of ginseng polysaccharides on tumor and immunological function in tumor-bearing mice].
    Qian BC; Zang XX; Li B; Xu CY; Peng XY
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):277-80. PubMed ID: 2959029
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer immunity after treatment of Ehrlich tumor with diphtheria toxin.
    Buzzi S; Buzzi L
    Cancer Res; 1974 Dec; 34(12):3481-6. PubMed ID: 4429964
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced tumor defence against solid Ehrlich-ascites tumor and sarcoma 180 mediated by a normal serum factor; comparison with tumor sera.
    Gillissen G; Schweizer K; Böckmann G
    Res Exp Med (Berl); 1974; 163(4):271-88. PubMed ID: 4432003
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-specific transplantation resistance in mice after treatment of initial tumors with Streptococcus thermophilus.
    Kaklij GS; Kelkar SM
    Microbiol Immunol; 1996; 40(1):55-8. PubMed ID: 8871529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.